CHME vs JNJ: Which Stock is Better?
Side-by-side comparison of China Medicine Corporation and Johnson & Johnson in 2026
CHME
China Medicine Corporation
$0.02
JNJ
Johnson & Johnson
$234.18
Key Metrics Comparison
| Metric | CHME | JNJ | Winner |
|---|---|---|---|
| Market Cap | $0.47M | $564.35B | JNJ |
| P/E Ratio | N/A | 21.23 | JNJ |
| EPS (TTM) | $N/A | $11.03 | JNJ |
| Revenue Growth | -0.1% | 0.1% | JNJ |
| Gross Margin | 33.5% | 68.0% | JNJ |
Analyze CHME
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHME or JNJ a better investment?
Comparing CHME and JNJ: China Medicine Corporation has a market cap of $0.47M while Johnson & Johnson has $564.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHME and JNJ?
CHME (China Medicine Corporation) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHME or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHME or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.1% for CHME.
Which company is more profitable: CHME or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 33.5% for CHME.
Which is the larger company: CHME or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $564.35B compared to $0.47M for CHME.
Should I buy CHME or JNJ in 2026?
Both CHME and JNJ have investment merit. CHME trades at $0.02 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHME and JNJ stock?
Key differences: Market Cap ($0.47M vs $564.35B), P/E Ratio (N/A vs 21.2x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (33.5% vs 68.0%).